Oxytocin Acetate for Laboratory Research

Oxytocin acetate is the acetate salt of a cyclic, C-terminally amidated nonapeptide. The defined sequence contains nine amino-acid residues. Its Cys1–Cys6 disulfide closes a six-residue ring, while the short C-terminal segment ends in glycinamide. The disulfide bridge and terminal amide are integral parts of the covalent identity, not presentation details.

The free-base formula and average mass differ from the monoacetate-salt formula and average mass by one equivalent of acetic acid. These paired database identities do not establish which form is present in received material. A product designation, chemical form, batch code and applicable documentation should therefore remain connected.

Identity source: Kimura et al. 1992 · PMID 1313946

Acetate is a counterion rather than an additional amino-acid residue. Gross salt mass and peptide content are consequently not interchangeable quantities. Documented water and other recorded components can also affect material balance. Any quantitative interpretation should follow the batch-specific assay and applicable quality documentation rather than the theoretical formula alone.

HPLC may document a method-specific chromatographic result for the tested batch, while MS may support molecular identity when recorded for that batch. Neither method answers every question alone. The useful documentary chain connects the batch, method, result and acceptance criterion, while maintaining the distinction between free-base identity and acetate-salt composition.

Study source: Riley et al. 1996 · PMID 8691097

This section describes findings in controlled research and makes no statement about use. The records progress chronologically across eight distinct evidence settings. Model, material, method and measured endpoint delimit every entry.

Study sources: the eight linked PubMed records above define this evidence map.

A human receptor expression-cloning study and an in-vitro human receptor structural study address receptor architecture under their stated systems. In-vitro ovine receptor pharmacology and in-vitro human receptor pharmacology address assay-specific interactions or signalling measurements. Signals from a human neuroimaging study are indirect and study-specific. A preclinical rat model remains species- and design-bound. These evidence levels cannot be combined as though they were equivalent.

The human cohort study of endogenous measurements assessed endogenous oxytocin measurements and cortisol-related HPA-axis reactivity, and did not characterise externally supplied oxytocin acetate reagent. Endogenous measurement and an experiment with laboratory reagent answer different research questions. Likewise, a database identity describes a referenced molecular entity, study material belongs to a stated publication, and delivered material requires its own documentary chain.

The cited papers do not establish identity, purity, content, salt equivalence or physical form for supplied material. Agreement across biological observations cannot validate a commercial batch. Literature assignment should preserve molecule, model, method and endpoint; product-specific questions require the applicable label, released specification and batch documentation.

Oxytocin acetate is a cyclic nonapeptide associated with OXTR. Kisspeptin-10 is associated with KISS1R; DSIP is a linear nonapeptide without a disulfide ring; VIP is a C-terminally amidated 28-mer; Selank and Semax are neuropeptide fragments; and Thymosin Alpha-1 belongs to a separate peptide class. These are identity distinctions only. Their identifiers, analytical expectations and literature records do not transfer to oxytocin acetate.

Evidence-boundary sources: Kirsch et al. 2005 · PMID 16339042 · Cox et al. 2015 · PMID 25768266

Physical form, stated content, binding storage conditions and stability period remain open points to be established from the released product information and applicable batch documentation. No presentation, numerical content, temperature or stability interval is inferred from molecular literature or database identity.

The documentation chain should connect product designation, chemical form, batch code, analytical method and reported result. A batch COA should connect the product name and batch code to the stated tests. HPLC may provide a batch-specific chromatographic result, while MS may support identity if such evidence is reported. Any numerical purity applies only to the analysed batch and stated method.

Oxytocin acetate is supplied to laboratories in the EU as research material. Publications define research questions and model-qualified measurements; they do not certify delivered identity, content, physical form, purity, salt equivalence or stability. Those properties require reconciliation against the applicable label, released specification and batch documentation.

Research use only. For laboratory research only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease. Not a medicinal product, food or cosmetic.